Risk Characterization in Patients Using Benzodiazepines While Providing Pharmaceutical Care Dispensing Service.
Daida Alberto ArmasVerónica Hernández GarcíaYanira Román CastilloJuan Ramón Santana AyalaFranc Capdevila FinestresArturo Hardisson de la TorreCarmen Rubio-ArmendárizPublished in: Pharmacy (Basel, Switzerland) (2024)
The community pharmacy, through protocolized care practices and supported by tools such as the Tyrer test, can play a decisive role in the detection, prevention, and resolution of the risks associated with BZD treatments.